Cargando…

Histone Deacetylase Adaptation in Single Ventricle Heart Disease and a Young Animal Model of Right Ventricular Hypertrophy

BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising therapeutics for various forms of cardiac disease. The purpose of this study was to assess cardiac HDAC catalytic activity and expression in children with single ventricle heart disease of right ventricular morphology (SV), as well as i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blakeslee, Weston W., Demos-Davies, Kimberly M., Lemon, Douglas D., Lutter, Katharina M., Cavasin, Maria A., Payne, Sam, Nunley, Karin, Long, Carlin S., McKinsey, Timothy A., Miyamoto, Shelley D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599335/ https://www.ncbi.nlm.nih.gov/pubmed/28549058 http://dx.doi.org/10.1038/pr.2017.126

Ejemplares similares

Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition
por: Cavasin, Maria A, et al.
Publicado: (2014)

Estrogen regulates histone deacetylases to prevent cardiac hypertrophy
por: Pedram, Ali, et al.
Publicado: (2013)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
por: Sandonà, Martina, et al.
Publicado: (2023)

Acute Kidney Injury Results in Long-Term Diastolic Dysfunction That Is Prevented by Histone Deacetylase Inhibition
por: Soranno, Danielle E., et al.
Publicado: (2021)

DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy
por: Ferguson, Bradley S., et al.
Publicado: (2021)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)

Histone Deacetylase 6 Inhibition Restores Leptin Sensitivity and Reduces Obesity
por: Çakır, Işın, et al.
Publicado: (2022)

Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
por: Kee, Hae Jin, et al.
Publicado: (2011)

Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy
por: Eom, Gwang Hyeon, et al.
Publicado: (2015)

The role of histone deacetylase 4 during chondrocyte hypertrophy and endochondral bone development
por: Chen, Zhi, et al.
Publicado: (2020)

The Level of Histone Deacetylase 4 is Associated with Aging Cartilage Degeneration and Chondrocyte Hypertrophy
por: Dong, Zhengquan, et al.
Publicado: (2022)

Endoplasmic Reticulum Stress Effector CCAAT/Enhancer‐binding Protein Homologous Protein (CHOP) Regulates Chronic Kidney Disease–Induced Vascular Calcification
por: Miyazaki‐Anzai, Shinobu, et al.
Publicado: (2014)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

MicroRNA-381 Regulates Chondrocyte Hypertrophy by Inhibiting Histone Deacetylase 4 Expression
por: Chen, Weishen, et al.
Publicado: (2016)

Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes
por: Angiolilli, Chiara, et al.
Publicado: (2017)

Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture
por: McKinsey, Timothy A., et al.
Publicado: (2018)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Pressure Overload-Induced Cardiac Hypertrophy Response Requires Janus Kinase 2-Histone Deacetylase 2 Signaling
por: Ying, Huang, et al.
Publicado: (2014)

Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice
por: Kee, Hae Jin, et al.
Publicado: (2019)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
por: Alzoubi, Samer, et al.
Publicado: (2016)

Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy
por: Haery, Leila, et al.
Publicado: (2015)

Histone deacetylase inhibitors as novel anticancer therapeutics
por: Walkinshaw, D.R., et al.
Publicado: (2008)

Aortic Stiffness, Left Ventricle Hypertrophy, and Homogeneity of Ventricle Repolarization in Adult Dialyzed Patients
por: Zapolski, Tomasz, et al.
Publicado: (2012)

Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
por: Huang, Ying, et al.
Publicado: (2011)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

Effect of adenotonsillar hypertrophy on right ventricle function in children
por: Lee, Jin Hwan, et al.
Publicado: (2014)

Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
por: Hai, Yang, et al.
Publicado: (2017)

Epigenetic control of signaling networks involved in interleukin-18-induced cardiac hypertrophy and its attenuation by pan-histone deacetylase inhibitors
por: Majumdar, Gipsy, et al.
Publicado: (2010)

Casein Kinase-2 Interacting Protein-1 Regulates Physiological Cardiac Hypertrophy via Inhibition of Histone Deacetylase 4 Phosphorylation
por: Zhao, Yinlong, et al.
Publicado: (2021)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Histone deacetylases in RA: epigenetics and epiphenomena
por: Grabiec, Aleksander M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5d0b06elfl8cnu45am7mffeb82